These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of hyperlipidemia of kidney disease. Grundy SM Kidney Int; 1990 Mar; 37(3):847-53. PubMed ID: 2179614 [No Abstract] [Full Text] [Related]
6. Lipid disorders and cardiovascular risks in nephrology. Dairou F Nephrol Dial Transplant; 1998; 13 Suppl 4():30-3. PubMed ID: 9614662 [No Abstract] [Full Text] [Related]
7. [Dyslipidemias in renal diseases: pathogenesis and treatment]. Cuevas A; Maíz A; Arteaga A Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303 [TBL] [Abstract][Full Text] [Related]
8. Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome. Ongkingco JR; Mann WA; Ruley EJ; Gregg RE Child Nephrol Urol; 1991; 11(2):107-10. PubMed ID: 1756519 [TBL] [Abstract][Full Text] [Related]
15. [What are the possibilities for treatment of hyperlipidemia in kidney insufficiency or in dialysis patients?]. Grützmacher P; Scheuermann E Med Welt; 1982 Jun; 33(24):873-4. PubMed ID: 7109928 [No Abstract] [Full Text] [Related]
17. Treatment of hyperlipidemia in nephrotic syndrome: time for a change? Olbricht CJ; Koch KM Nephron; 1992; 62(2):125-9. PubMed ID: 1436302 [No Abstract] [Full Text] [Related]
18. [Secondary hyperlipoproteinemias]. Reuter W Z Gesamte Inn Med; 1978 Nov; 33(22):817-22. PubMed ID: 284668 [TBL] [Abstract][Full Text] [Related]